hon-20250401
FALSE000077384000007738402025-04-012025-04-010000773840us-gaap:CommonStockMember2025-04-012025-04-010000773840hon:A3500SeniorNotesDue2027Member2025-04-012025-04-010000773840hon:Euro225NotesDue2028Member2025-04-012025-04-010000773840hon:Euro3.375SeniorNotesDue2030Member2025-04-012025-04-010000773840hon:Euro75TermLoanDue2032Member2025-04-012025-04-010000773840hon:A3.750SeniorNotesDue2032Member2025-04-012025-04-010000773840hon:Euro4125SeniorNotesDue2034Member2025-04-012025-04-010000773840hon:Euro3.75SeniorNotesDue2036Member2025-04-012025-04-01

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
Form 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT – April 1, 2025
(Date of earliest event reported)
 
HONEYWELL INTERNATIONAL INC.
(Exact name of Registrant as specified in its Charter)
 
Delaware1-897422-2640650
(State or other jurisdiction of
incorporation)
(Commission File Number)(I.R.S. Employer Identification
Number)

855 S. MINT STREET, CHARLOTTE, NC..................................................28202
......(Address of principal executive offices).................................................(Zip Code)

 Registrant’s telephone number, including area code: (704) 627-6200

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $1 per shareHONThe Nasdaq Stock Market LLC
3.500% Senior Notes due 2027HON 27The Nasdaq Stock Market LLC
2.250% Senior Notes due 2028HON 28AThe Nasdaq Stock Market LLC
3.375% Senior Notes due 2030HON 30The Nasdaq Stock Market LLC
0.750% Senior Notes due 2032HON 32The Nasdaq Stock Market LLC
3.750% Senior Notes due 2032HON 32AThe Nasdaq Stock Market LLC
4.125% Senior Notes due 2034HON 34The Nasdaq Stock Market LLC
3.750% Senior Notes due 2036HON 36The Nasdaq Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  




Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On April 1, 2025, Stephen Williamson, 58, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., was appointed to the Board of Directors of Honeywell International Inc. (the “Company”) as an independent director and member of the Audit Committee, effective April 1, 2025. Mr. Williamson will stand for election at the Company’s 2025 Annual Meeting of Shareowners. He will receive compensation as a non-employee director in accordance with the Company's previously-disclosed non-employee director compensation practices.

Item 7.01    Regulation FD Disclosure

On April 1, 2025, the Company issued the press release attached hereto as Exhibit 99.1 with respect to the matters set forth in Item 5.02 above.

The information in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01    Financial Statements and Exhibits

(d) Exhibits

The following exhibits are filed as part of this report:

Exhibit #
Description
99.1
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).




SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Date:April 1, 2025HONEYWELL INTERNATIONAL INC. 
    
 
By: /s/ Su Ping Lu
 Su Ping Lu
 Vice President and Corporate Secretary
    


Document


Exhibit 99.1
https://cdn.kscope.io/2d0488b2675fd3ae6fe321d3fa9bac3e-image_0.jpg 
 
Contacts:
 
  
MediaInvestor Relations
Stacey JonesSean Meakim
(980) 378-6258(704) 627-6200
stacey.jones@honeywell.comsean.meakim@honeywell.com

HONEYWELL APPOINTS STEPHEN WILLIAMSON TO BOARD OF DIRECTORS

CHARLOTTE, N.C., April 1, 2025 -- Honeywell (NASDAQ: HON) announced today that its Board of Directors has elected Stephen Williamson, 58, current Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., to its Board of Directors as an independent Director and Audit Committee member, effective April 1, 2025.
Williamson was named Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific in August 2015 and is responsible for the company’s finance, tax, M&A, treasury and global business services functions. After joining Thermo Fisher Scientific in July 2001, he held a variety of finance leadership roles including Vice President of Financial Operations, leading the finance support function company-wide, and Vice President, European Financial Operations, overseeing integration activities across Europe.
Prior to working at Thermo Fisher Scientific, Williamson held various finance positions at Honeywell, including Vice President and Chief Financial Officer, Asia Pacific and other corporate development and operational finance roles. Williamson began his career with Price Waterhouse in the transaction support group and the audit practice.
“We are delighted to welcome Stephen to our Board of Directors. He brings extensive financial expertise and significant international business experience,” said Vimal Kapur, Chairman and Chief Executive Officer of Honeywell. “Stephen’s broad industry knowledge and M&A experience will be invaluable to Honeywell as we pursue our transformational objectives and continue to drive growth and innovation globally.”
Williamson holds a bachelor's degree in accounting and finance from the University of Wales and is a member of the Institute of Chartered Accountants of England and Wales.

About Honeywell
Honeywell is an integrated operating company serving a broad range of industries and geographies around the world. Our business is aligned with three powerful megatrends – automation, the future of aviation and energy transition – underpinned by our Honeywell Accelerator operating system and Honeywell Forge IoT platform. As a trusted partner, we help organizations solve the world's toughest, most complex challenges, providing actionable solutions and innovations through our Aerospace Technologies, Industrial Automation, Building Automation and Energy and Sustainability Solutions business segments that help make the world smarter, safer, as well as more secure and sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.



We describe many of the trends and other factors that drive our business and future results in this release. Such discussions contain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). Forward-looking statements are those that address activities, events, or developments that management intends, expects, projects, believes, or anticipates will or may occur in the future. They are based on management's assumptions and assessments in light of past experience and trends, current economic and industry conditions, expected future developments, and other relevant factors, many of which are difficult to predict and outside of our control. They are not guarantees of future performance, and actual results, developments and business decisions may differ significantly from those envisaged by our forward-looking statements. We do not undertake to update or revise any of our forward-looking statements, except as required by applicable securities law. Our forward-looking statements are also subject to material risks and uncertainties, including ongoing macroeconomic and geopolitical risks, such as lower GDP growth or recession, capital markets volatility, inflation, and certain regional conflicts, that can affect our performance in both the near- and long-term. In addition, no assurance can be given that any plan, initiative, projection, goal, commitment, expectation, or prospect set forth in this release can or will be achieved. These forward-looking statements should be considered in light of the information included in this release, our Form 10-K and other filings with the Securities and Exchange Commission. Any forward-looking plans described herein are not final and may be modified or abandoned at any time.